Reutova, E. V., & Laktionov, K. K. (2021). Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: New features. IP Habib O.N.
Style de citation Chicago (17e éd.)Reutova, Elena V., et Konstantin K. Laktionov. Antiangiogenic Therapy in Pretreated Patients with Lung Adenocarcinoma Without Activating Mutations: New Features. IP Habib O.N, 2021.
Style de citation MLA (8e éd.)Reutova, Elena V., et Konstantin K. Laktionov. Antiangiogenic Therapy in Pretreated Patients with Lung Adenocarcinoma Without Activating Mutations: New Features. IP Habib O.N, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.